National brain tumour research funding needs to increase to £35 million a year
Dame Sheila Hancock supports our campaigning
This weekend we were pleased to keep brain tumours in the spotlight with television interviews to support our cause.
On Saturday, Dame Sheila Hancock was interviewed on Sky News and spoke about the need to campaign for increased investment change outcomes for brain tumour patients. Sheila has been a friend of the charity for many years following her grandson Jack’s diagnosis with a brain tumour at the age of four, and she has been invaluable in the support she has provided in raising awareness of brain tumours.
She said: “On the ground we have to fight and make the Government realise how important it is to continue this research, which has obviously been hit terribly by things that have been happening in the past year because charities are all suffering.”
Edward Ruggiero is working with Brain Tumour Research to share his story to support our petition. Edward was diagnosed with a grade 3 anaplastic astrocytoma in 2017 and underwent surgery, but contracted a life-threatening infection which meant he needed a further operation to remove part of his skull. Edward, who has decided not to continue his chemotherapy treatment, was featured on Sky News on Sunday as part of their coverage of our campaigning. Also interviewed were our Head of Stakeholder Relations, Hugh Adams, and Professor Silvia Marino, Principal Investigator at our Centre of Excellence at Queen Mary University of London.
Elsewhere, postman Matt Shanley spoke about the impact of his brain tumour diagnosis in an interview with ITV Anglia. He explained how he lives with sight loss, muscle weakness and seizures following his surgery to remove a subependymoma in 2018 and is taking part in Wear A Hat Day with his wife Julie to raise vital funds and awareness.
If you have a story you’d like to share, please contact our PR team on email@example.com
If you found this story interesting or helpful, sign up to our weekly e-news and keep up to date with all the latest from Brain Tumour Research.